Avalo Therapeutics, Inc. (AVTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 243.43M |
| Enterprise Value | 230M |
| P/E Ratio | -2.93 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 3,269.55 |
| Price/Book Ratio | 5.03 |
| Enterprise/Revenue | 2,885.48 |
| Enterprise/EBITDA | -2.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1,436.27 |
| Operating Margin | -1,341.64 |
| Return On Assets | -0.85 |
| Return On Equity | -0.98 |
| Revenue | 59,000 |
| Revenue/Share | 0 |
| Gross Profit | 59,000 |
| EBITDA | -77.75M |
| Net Income | -78.26M |
| Diluted EPS | -5.84 |
| Total Cash | 81.99M |
| Total Cash/Share | 4.08 |
| Total Debt | 2.33M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 7.66 |
| Book Value Per Share | 3.4 |
| 52-Week Change | 256.58 |
| 52-Week High | 24.27 |
| 52-Week Low | 4.5 |
| Moving Average 50 Days | 15.5 |
| Moving Average 200 Days | 15.6 |
| Average Volume | 1.72M |
| Shares Outstanding | 11.29M |
| % Held by Institutions | 232.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:240 |
| Last Split Date | December 29, 2023 |